Finance

Lists
TRVI:NASDAQ
Trevi Therapeutics Inc
၁၂.၉၃ US$
-၁.၉၇%
(-၀.၂၆) 1D
၁၂.၉၃ US$
၀.၀၀% (၀.၀၀)
After hours
Closed: အောက် ၁၂, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TRVI...
Open
၁၃.၁၄ US$
High
၁၃.၄၆ US$
Low
၁၂.၈၁ US$
Mkt. cap
၁၈၄.၂၂ ဋေ
Avg. vol.
၂.၂၀ သန်း
Volume
၄.၇၇ သန်း
52-wk high
၂၀.၁၅ US$
52-wk low
၉.၂၉ US$
EPS
-၀.၃၄ US$
Beta
၀.၉၈
Shares outstanding
၁၄.၂၅ ကုဋေ
No. of employees
၃၄
Open
၁၃.၁၄ US$
High
၁၃.၄၆ US$
Low
၁၂.၈၁ US$
Mkt. cap
၁၈၄.၂၂ ဋေ
Avg. vol.
၂.၂၀ သန်း
Volume
၄.၇၇ သန်း
52-wk high
၂၀.၁၅ US$
52-wk low
၉.၂၉ US$
EPS
-၀.၃၄ US$
Beta
၀.၉၈
Shares outstanding
၁၄.၂၅ ကုဋေ
No. of employees
၃၄
News stories
From web sources and news partners
Benzinga
Benzinga
·
ပြီးခဲ့သည့် ၁၇ နာရီ
Trevi Therapeutics Q2 2026 Earnings Call Transcript
About Trevi Therapeutics Inc
CEO-
Employees၃၄
Founded၂၀၁၁
Headquartersနယူး ဟဲဗန်း, ကွန်​နက်​တီ​ကတ်​ပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Analyst ratings
Based on 10 analysts giving stock ratings to TRVI in the past 3 months
Strong buy
Buy
10
Hold
0
Sell
0
12-month forecast
Based on 10 Wall Street analysts offering 12 month price targets for TRVI in the last 3 months.
Highest
Current ၁၂.၉၃ US$
၄၀.၀၀ US$ (+၂၀၉.၃၆%)
Average
၂၉.၀၀ US$ (+၁၂၄.၂၈%)
Lowest
၂၃.၀၀ US$ (+၇၇.၈၈%)
Analyst
Recommendation
Action
Price target
Projected
Date
Conor MacKay
BMO Capital
Buy
Maintained
၃၆.၀၀ US$
+၁၇၈.၄%
10/06/2026
Brandon Folkes
H.C. Wainwright
Buy
Maintained
၂၄.၀၀ US$
+၈၅.၆%
09/21/2026
Debanjana Chatterjee
JonesTrading
Buy
Reiterated
၂၈.၀၀ US$
+၁၁၆.၆%
08/13/2026
Judah Frommer
Morgan Stanley
Buy
Reiterated
၂၃.၀၀ US$
+၇၇.၉%
08/10/2026
Serge Belanger
Needham
Buy
Maintained
၂၃.၀၀ US$
+၇၇.၉%
08/07/2026
Ryan Deschner
Raymond James
Buy
Maintained
၄၀.၀၀ US$
+၂၀၉.၄%
08/07/2026
Mayank Mamtani
B. Riley Securities
Buy
Initiated
၃၁.၀၀ US$
+၁၃၉.၈%
08/07/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Reiterated
၃၀.၀၀ US$
+၁၃၂%
08/06/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
၂၅.၀၀ US$
+၉၃.၃%
08/07/2026
Annabel Samimy
Stifel Nicolaus
Buy
Reiterated
၃၀.၀၀ US$
+၁၃၂%
08/07/2026
Evan Seigerman
BMO Capital
Buy
Initiated
၃၆.၀၀ US$
+၁၇၈.၄%
07/21/2026
Unknown Analyst
BMO Capital
Buy
Initiated
၃၆.၀၀ US$
+၁၇၈.၄%
07/20/2026
William Wood
B. Riley Securities
Buy
Reiterated
၃၁.၀၀ US$
+၁၃၉.၈%
07/17/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
၂၉.၀၀ US$
+၁၂၄.၃%
05/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၁.၀၁ ကုဋေ
၆.၁၉ သန်း
၉.၉၄ သန်း
၁.၅၂ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၈၃ သန်း
၄.၀၃ သန်း
၄.၉၇ သန်း
၅.၃၆ သန်း
Operating expense
၁.၃၉ ကုဋေ
၁.၀၂ ကုဋေ
၁.၄၉ ကုဋေ
၂.၀၅ ကုဋေ
Total operating expenses
၁.၃၉ ကုဋေ
၁.၀၂ ကုဋေ
၁.၄၉ ကုဋေ
၂.၀၅ ကုဋေ
Operating income
-၁.၃၉ ကုဋေ
-၁.၀၂ ကုဋေ
-၁.၄၉ ကုဋေ
-၂.၀၅ ကုဋေ
Other non operating income
-၂.၀၀ ထောင်
-၁.၅၀ သောင်း
-
-
EBT including unusual items
-၁.၁၈ ကုဋေ
-၈.၃၃ သန်း
-၁.၃၂ ကုဋေ
-၁.၇၈ ကုဋေ
EBT excluding unusual items
-၁.၁၈ ကုဋေ
-၈.၃၃ သန်း
-၁.၃၂ ကုဋေ
-၁.၇၈ ကုဋေ
Income tax expense
-၁.၅၀ သောင်း
-၁.၆၀ သောင်း
-၂.၀၀ သောင်း
-၁.၉၀ သောင်း
Effective tax rate
၀.၁၃%
၀.၁၉%
၀.၁၅%
၀.၁၁%
Other operating expenses
-
-
-
-
Net income
-၁.၁၈ ကုဋေ
-၈.၃၂ သန်း
-၁.၃၂ ကုဋေ
-၁.၇၈ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၀.၀၈
-၀.၀၆
-၀.၀၉
-၀.၁၁
Interest and investment income
၂.၁၀ သန်း
၁.၉၀ သန်း
၁.၇၀ သန်း
၂.၇၀ သန်း
Interest expense
-
-
-
-
Net interest expenses
၂.၁၀ သန်း
၁.၉၀ သန်း
၁.၇၀ သန်း
၂.၇၀ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၁.၃၉ ကုဋေ
-၁.၀၂ ကုဋေ
-၁.၄၉ ကုဋေ
-၂.၀၅ ကုဋေ
Gain or loss from assets sale
-
၇.၀၀ ထောင်
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google အက်ပ်များ